Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Eluting Stents (DES)”

160 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 160 results

Not applicableEnded earlyNCT01892917
What this trial is testing

BIOFLOW-III Hungary Satellite Registry

Who this might be right for
Coronary Artery DiseaseMyocardial Ischemia
Biotronik Hungária Kft. 2,000
Post-approval studies (Phase 4)Active Not RecruitingNCT03947229
What this trial is testing

Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Who this might be right for
Coronary Artery DiseaseDES
Yonsei University 3,200
Not applicableActive Not RecruitingNCT02593994
What this trial is testing

IRIS-Onyx Cohort in the IRIS-DES Registry

Who this might be right for
Coronary Artery DiseaseArterial Occlusive DiseasesCardiovascular Diseases+1 more
Seung-Jung Park 4,500
Not applicableStudy completedNCT02978456
What this trial is testing

Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation

Who this might be right for
Coronary DiseaseCoronary Stenoses
CHEOL WHAN LEE, M.D., Ph.D 1,528
Post-approval studies (Phase 4)Study completedNCT00323895
What this trial is testing

The Intra-Drug Eluting Stent (DES) Restenosis Study

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 320
Not applicableStudy completedNCT00754975
What this trial is testing

JACTAX LD Drug Eluting Stent Trial

Who this might be right for
Coronary Artery Disease
Boston Scientific Corporation 130
Post-approval studies (Phase 4)Ended earlyNCT00936780
What this trial is testing

Infinnium-Core™ Registry for the Treatment of Patients With De Novo Coronary Lesions

Who this might be right for
Coronary Artery Disease
Sahajanand Medical Technologies Limited 67
Testing effectiveness (Phase 2)Study completedNCT01247428
What this trial is testing

First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Micell Technologies 30
Not applicableStudy completedNCT01667757
What this trial is testing

Optimal Physiologic Intravascular Ultrasound Imaging Criteria After Drug Eluting Stent Implantation

Who this might be right for
Coronary Disease
Inje University 200
Not applicableUnknownNCT03589157
What this trial is testing

Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined With Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: a Prospective, Randomized, Controlled Clinical Trial

Who this might be right for
Diffuse Coronary Artery Lesions
Chinese PLA General Hospital 140
Large-scale testing (Phase 3)Study completedNCT03551496
What this trial is testing

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

Who this might be right for
Critical Limb Ischemia
Boston Scientific Corporation 201
Not applicableStudy completedNCT02099565
What this trial is testing

Observational Prospective Study OPTIMA II - Follow-up

Who this might be right for
Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
AstraZeneca 572
Not applicableStudy completedNCT01121744
What this trial is testing

Supralimus-Core™ Pharmacokinetic (PK) Study

Who this might be right for
Coronary Artery Disease
Sahajanand Medical Technologies Limited 20
Testing effectiveness (Phase 2)Study completedNCT01405287
What this trial is testing

Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT

Who this might be right for
Coronary Artery DiseaseAtherosclerosisAcute Coronary Syndrome (ACS)+1 more
OrbusNeich 60
Not applicableStudy completedNCT02028728
What this trial is testing

BIOFLOW III Satellite-Italy Orsiro Stent System

Who this might be right for
Coronary Artery Diseases
Biotronik Italia S.p.A. 609
Post-approval studies (Phase 4)Looking for participantsNCT06855537
What this trial is testing

Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques

Who this might be right for
Coronary Arterial Disease (CAD)Vulnerable Coronary PlaquesThin-cap fIbroatheroma+1 more
Beijing Anzhen Hospital 2,190
Not applicableUnknownNCT03375528
What this trial is testing

Matrix Metalloproteinases Expression in the Neointimal Hyperplasia Induced by Drug Eluting Stent (DES) Implantation

Who this might be right for
Coronary Artery DiseaseStent Restenosis
Dankook University 50
Not applicableStudy completedNCT04415216
What this trial is testing

DEB vs Thin-DES in DES-ISR: Long Term Outcomes (DEB Dragon Registry)

Who this might be right for
In Stent Restenosis
Medical University of Silesia 1,369
Large-scale testing (Phase 3)UnknownNCT00471289
What this trial is testing

PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

Who this might be right for
Peripheral Vascular Disease
Netherlands Society for Interventional Radiology 144
Post-approval studies (Phase 4)Study completedNCT00376571
What this trial is testing

Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions?

Who this might be right for
Coronary Artery Disease
Aarhus University Hospital Skejby 413
Load More Results